Related Experiment Video
Updated: May 26, 2026

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
Published on: July 19, 2007
Senate stalling derails bill to fix Canada's law on affordable generic medicines for developing countries
Lindsey Amèrica-Simms1, Richard Elliott
1Canadian HIV/AIDS Legal Network. lsimms@aidslaw.ca
Abstract:
On 26 March 2011, when Parliament was dissolved for a federal election, Bill C-393 died on the Order Paper. The bill addressed flaws in Canada's Access to Medicines Regime (CAMR), which is supposed to facilitate the export of lower-cost medications, including HIV treatments, to developing countries.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Regulation
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Control Governance: Regulatory Bodies and Their Impact
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

